Search Results - "Begelman, Susan M"

Relationship Between Serum Low-Density Lipoprotein Cholesterol and In-hospital Mortality Following Acute Myocardial Infarction (The Lipid Paradox) by Reddy, Vanessa S., MS, Bui, Quang T., MD, Jacobs, Joan R., MA, Begelman, Susan M., MD, Miller, Dave P., MS, French, William J., MD

“…Lipoprotein levels are currently recognized as independent risk factors for long-term cardiovascular events after acute myocardial infarction (AMI). During the…”
Get full text

Manifestations of Cardiac Disease in Carotid Duplex Ultrasound Examination by Madhwal, Surabhi, MD, Yesenko, Sandra, RVT, Kim, Esther Soo Hyun, MD, Park, Margaret, RDCS, RVT, Begelman, Susan M., MD, Gornik, Heather L., MD, MHS

Get full text

Previous Myocardial Infarction as a Risk Factor for In-Hospital Cardiovascular Outcomes (from the National Registry of Myocardial Infarction 4 and 5) by Bui, Quang T., MD, Reddy, Vanessa S., MS, Jacobs, Joan R., MA, Begelman, Susan M., MD, Frederick, Paul D., MPH, MBA, Miller, Dave P., MS, French, William J., MD

“…Patients with acute coronary syndromes have a substantial disease burden and are at continued risk of future cardiovascular events. In this setting, the…”
Get full text

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Improvement of Hemodialysis Catheter Function: TROPICS 3 by Tumlin, James, Goldman, Jesse, Spiegel, David M, Roer, David, Ntoso, K. Adu, Blaney, Martha, Jacobs, Joan, Gillespie, Barbara S, Begelman, Susan M

“…Despite widespread use of tunneled hemodialysis (HD) catheters, their utility is limited by the development of thrombotic complications. To address this…”
Get full text

A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters by Tebbi, Cameron, MD, Costanzi, John, MD, Shulman, Robert, MD, Dreisbach, Luke, MD, Jacobs, Brian R., MD, Blaney, Martha, PharmD, Ashby, Mark, PhD, Gillespie, Barbara S., MD, Begelman, Susan M., MD

“…Purpose To evaluate, in a phase III, single-arm study, the safety and efficacy of the thrombolytic agent tenecteplase in restoring function to dysfunctional…”
Get full text

TROPICS 1: A Phase III, Randomized, Double-blind, Placebo-controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters by Gabrail, Nashat, MD, Sandler, Eric, MD, Charu, Veena, MD, Anas, Nick, MD, Lim, Eduardo, MD, Blaney, Martha, PharmD, Ashby, Mark, PhD, Gillespie, Barbara S., MD, Begelman, Susan M., MD

“…Purpose To evaluate the efficacy and safety of the thrombolytic tenecteplase, a fibrin-specific recombinant tissue plasminogen activator, for restoring…”
Get full text

Presence of Carotid and Peripheral Arterial Disease in Patients With Left Main Disease by Doonan, Aaron L., MD, Karha, Juhana, MD, Carrigan, Thomas P., MD, Bavry, Anthony A., MD, MPH, Begelman, Susan M., MD, Ellis, Stephen G., MD, Yadav, Jay, MD, Bhatt, Deepak L., MD

“…Left main (LM) coronary disease, carotid artery disease, and peripheral arterial disease each reflects advanced atherosclerosis. The frequency of their…”
Get full text

Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis by Napalkov, Pavel, Felici, Diana M, Chu, Laura K, Jacobs, Joan R, Begelman, Susan M

“…Central venous catheter (CVC) and hemodialysis (HD) catheter usage are associated with complications that occur during catheter insertion, dwell period, and…”
Get full text

Noninvasive diagnostic strategies for peripheral arterial disease by Begelman, Susan M, Jaff, Michael R

“…A variety of diagnostic methods for peripheral arterial disease (PAD) are available, each with strengths and limitations. The ankle-brachial index is a simple…”
Get full text

Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab’ fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study by Douketis, James D., Ginsberg, Jeffrey S., Haley, Susan, Julian, Jim, Dwyer, Miriam, Levine, Mark, Eisenberg, Paul R., Smart, Richard, Tsui, Wendy, White, Richard H., Morris, Timothy A., Kaatz, Scott, Comp, Philip C., Crowther, Mark A., Kearon, Clive, Kassis, Jeannine, Bates, Shannon M., Schulman, Sam, Desjardins, Louis, Taillefer, Raymond, Begelman, Susan M., Gerometta, Mike

“…The assessment of patients with suspected deep vein thrombosis (DVT) remains challenging despite current diagnostic algorithms. 99mTc-labelled DI-DD3B6/22-80B3…”
Get full text

Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly by Liu, Shuqian, Adelman, Daphne T, Xu, Yaping, Sisco, Jillone, Begelman, Susan M, Webb, Susan M, Badia, Xavier, Thethi, Tina K, Fonseca, Vivian, Shi, Lizheng

“…The study aimed to assess the economic burden, health-related quality of life (HRQoL), and acromegaly treatment satisfaction in the USA. A web-based,…”
Get full text

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis by Placzek, Hilary, Xu, Yaping, Mu, Yunming, Begelman, Susan M, Fisher, Maxine

“…Acromegaly is a chronic disorder characterized by excess growth hormone secretion and elevated insulin-like growth factor-1 levels most often caused by a…”
Get full text

Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials by Garrick, Owen, Mesa, Ruben, Ferris, Andrea, Kim, Edward S, Mitchell, Edith, Brawley, Otis W, Carpten, John, Carter, Keith D, Coney, Joseph, Winn, Robert, Monroe, Stephanie, Sandoval, Fabian, Perez, Edith, Williams, Mitzi, Grove, Evan, Highsmith, Quita, Richie, Nicole, Begelman, Susan M, Collins, Asha S, Freedman, Jamie, Gonzales, Melissa S, Wilson, Gerren

“…Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle…”
Get full text

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study by Douketis, James D, Ginsberg, Jeffrey S, Haley, Susan, Julian, Jim, Dwyer, Miriam, Levine, Mark, Eisenberg, Paul R, Smart, Richard, Tsui, Wendy, White, Richard H, Morris, Timothy A, Kaatz, Scott, Comp, Philip C, Crowther, Mark A, Kearon, Clive, Kassis, Jeannine, Bates, Shannon M, Schulman, Sam, Desjardins, Louis, Taillefer, Raymond, Begelman, Susan M, Gerometta, Mike

“…The assessment of patients with suspected deep vein thrombosis (DVT) remains challenging despite current diagnostic algorithms. (99m)Tc-labelled…”
Get full text

Fibromuscular dysplasia by Begelman, Susan M, Olin, Jeffrey W

“…Fibromuscular dysplasia is an uncommon angiopathy that occurs in young to middle-aged, predominately female individuals. The disease consists of a…”
Get full text

110: Tenecteplase for the Improvement of Blood Flow Rate in Dysfunctional Hemodialysis Catheters by Goldman, Jesse, Fishbane, Steven, Oliver, Matthew J, Blaney, Martha, Jacobs, Joan R, Begelman, Susan M

Get full text

Tenecteplase for the improvement of blood flow rate in dysfunctional hemodialysis catheters by Goldman, Jesse, Fishbane, Steven, Oliver, Matthew J, Blaney, Martha, Jacobs, Joan R, Begelman, Susan M

“…We evaluated the efficacy and safety of the thrombolytic agent tenecteplase for the treatment of dysfunctional hemodialysis (HD) catheters. Data were pooled…”
Get more information

Argatroban Anticoagulation in Intensive Care Patients: Effects of Heart Failure and Multiple Organ System Failure by Begelman, Susan M., Baghdasarian, Sarkis B., Singh, Inder M., Militello, Michael A., Hursting, Marcie J., Bartholomew, John R.

“…We retrospectively evaluated argatroban dosing patterns, clinical outcomes, and the effects of heart failure and multiple organ system failure on dosing…”
Get full text

Improvement of Hemodialysis Catheter Function with Tenecteplase: A Phase III, Open-Label Study: TROPICS 4 by Fishbane, Steven, Milligan, Samuel L., Lempert, Kenneth D., Hertel, Joachim E. W., Wetmore, James B., Oliver, Matthew J., Blaney, Martha, Gillespie, Barbara S., Jacobs, Joan R., Begelman, Susan M.

“…Hemodialysis (HD) catheters are prone to thrombotic occlusion. We evaluated tenecteplase, a thrombolytic, for the treatment of dysfunctional HD catheters…”
Get full text

Heparin-induced thrombocytopenia: principles for early recognition and management by Bartholomew, John R, Begelman, Susan M, Almahameed, Amjad

“…Heparin-induced thrombocytopenia (HIT) is a potentially devastating complication of therapy with either unfractionated or low-molecular-weight heparin…”
Get full text